Back to Network
4
Shared Docs
4
Same-Page
4 / 4
Mentions
Document Mentions (4 shared documents)
2 mentions1 same-page
Page ?Same page
ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human
ion for Research on Equal Opportunity Visiting Fellow Robert Bryce; and GRID Alternatives Policy and Regulatory Manager Alexandra Wyatt; 10:00 AM * House Agriculture subcommittee hybrid hearing on conservation programs — Conservation and Forestry Subcommittee hybrid hearing on `Challenges and Successes of Conserv
2 mentions1 same-page
Page ?Same page
ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human
ion for Research on Equal Opportunity Visiting Fellow Robert Bryce; and GRID Alternatives Policy and Regulatory Manager Alexandra Wyatt; 10:00 AM • House Agriculture subcommittee hybrid hearing on conservation programs - Conservation and Forestry Subcommittee hybrid hearing on 'Challenges and Successes of Conserv
2 mentions1 same-page
Page ?Same page
ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human
ion for Research on Equal Opportunity Visiting Fellow Robert Bryce; and GRID Alternatives Policy and Regulatory Manager Alexandra Wyatt; 10:00 AM • House Agriculture subcommittee hybrid hearing on conservation programs - Conservation and Forestry Subcommittee hybrid hearing on 'Challenges and Successes of Conse
Sponsored
2 mentions1 same-page
Page ?Same page
ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human
ion for Research on Equal Opportunity Visiting Fellow Robert Bryce; and GRID Alternatives Policy and Regulatory Manager Alexandra Wyatt; 10:00 AM • House Agriculture subcommittee hybrid hearing on conservation programs - Conservation and Forestry Subcommittee hybrid hearing on 'Challenges and Successes of Conse
Sponsored
Mutual Connections (945)
Entities connected to both Amgen and House Agriculture
Jeffrey Epstein
PERSON11 w/ Amgen·5 w/ House
Donald Trump
PERSON10 w/ Amgen·5 w/ House
Michael Jackson
PERSON9 w/ Amgen·5 w/ House
Stephen Hawking
PERSON7 w/ Amgen·5 w/ House
Julie K. Brown
PERSON7 w/ Amgen·5 w/ House
Philadelphia
LOCATION8 w/ Amgen·4 w/ House
Joe Biden
PERSON7 w/ Amgen·5 w/ House
Marc Rich
PERSON7 w/ Amgen·5 w/ House
George Mitchell
PERSON7 w/ Amgen·5 w/ House
United States
LOCATION8 w/ Amgen·4 w/ House
Prince Andrew
PERSON7 w/ Amgen·5 w/ House
Barack Obama
PERSON7 w/ Amgen·5 w/ House
Bloomberg L.P.
ORGANIZATION6 w/ Amgen·5 w/ House
Wilbur Ross
PERSON6 w/ Amgen·5 w/ House
Department of Justice
ORGANIZATION6 w/ Amgen·5 w/ House
ET
Emmy Taylor
PERSON6 w/ Amgen·5 w/ House
John Brennan
PERSON7 w/ Amgen·4 w/ House
Hillary Clinton
PERSON7 w/ Amgen·4 w/ House
Milwaukee
LOCATION6 w/ Amgen·5 w/ House
Michael Cohen
PERSON7 w/ Amgen·4 w/ House